Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

AIkido Pharma Inc (AIKI)

AIkido Pharma Inc (AIKI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 79,171
  • Shares Outstanding, K 88,906
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,340 K
  • 60-Month Beta 1.61
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.13
Trade AIKI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/13/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8204 +8.54%
on 04/16/21
1.4200 -37.29%
on 03/24/21
-0.3395 (-27.60%)
since 03/16/21
3-Month
0.8204 +8.54%
on 04/16/21
2.5500 -65.08%
on 02/16/21
-0.1995 (-18.30%)
since 01/15/21
52-Week
0.4656 +91.26%
on 11/02/20
2.5500 -65.08%
on 02/16/21
-0.0054 (-0.60%)
since 04/16/20

Most Recent Stories

More News
AIkido Pharma Notes Advancement in Radiopharmaceutical Research

, /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today noted that a recent study announced positive early results from a PSMA 617-Lu177 study conducted by a leading global...

AIKI : 0.8905 (-0.54%)
AIkido Granted Sublicense to Technology for Targeted Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients

, /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has been granted an exclusive sublicense to technology related to the use of novel and proprietary...

AIKI : 0.8905 (-0.54%)
AIkido Pharma Provides Business Update

, /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided a business update.

AIKI : 0.8905 (-0.54%)
Psychedelics Companies are Establishing Core IPs in Growing Market

, /PRNewswire/ -- The emerging psychedelics therapy market has been among the top financial stories of 2021 so far, driven by major legal and regulatory breakthroughs, promising research and groundbreaking...

PULL.CN : 0.395 (+1.28%)
PRXTF : 0.3120 (+2.16%)
FTRP.CN : 6.020 (+2.03%)
FTRPF : 4.8218 (+3.37%)
AIKI : 0.8905 (-0.54%)
RVV.CN : 0.430 (-2.27%)
RVVTF : 0.3440 (-1.71%)
CBDT.CN : 0.670 (-1.47%)
EPWCF : 0.5300 (-0.75%)
AIkido Pharma Sponsors Psychedelic Compound Research to Treat PTSD

, /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it is sponsoring psychedelic research at the Mount Sinai Center for Psychedelic Psychotherapy and...

AIKI : 0.8905 (-0.54%)
Why Canada is Becoming a Hub for Psychedelics Research and Development

, /PRNewswire/ -- has become home to some of the most important research and development happening today in the mental health and wellness space. Psychedelic therapy emerged as a breakthrough mental...

NUMI.VN : 0.900 (-2.17%)
LKYSF : 0.7204 (-1.32%)
CBDT.CN : 0.670 (-1.47%)
EPWCF : 0.5300 (-0.75%)
RVV.CN : 0.430 (-2.27%)
RVVTF : 0.3440 (-1.71%)
LITT.VN : 0.065 (-7.14%)
RMANF : 0.0450 (+4.90%)
AIKI : 0.8905 (-0.54%)
AIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology

, /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. appeared on the video podcast This Week in Virology, segment entitled "."  In the video, Dr....

AIKI : 0.8905 (-0.54%)
The Race to Prove Psychedelics Can Help Resolve Mental Health Issues Has Just Begun

The psychedelics story is gaining momentum, as NeonMind Biosciences (CSE:NEON) (OTC:NMDBF), Lobe ...

LOBE.CN : 0.140 (-3.45%)
GTSIF : 0.1150 (-0.61%)
MYCOF : 0.2749 (+1.81%)
AIKI : 0.8905 (-0.54%)
SEEL : 5.26 (-0.38%)
NMDBF : 0.1679 (-6.72%)
MYCO.CN : 0.340 (-1.45%)
NEON.CN : 0.210 (-6.67%)
AIkido Pharma Inc. Updates Announcement of Webcast Link for the H.C. Wainwright Global Life Sciences Conference (Virtual Event)

, /PRNewswire/ -- AIkido Pharma Inc. (: AIKI) ("AIkido" or the "Company") today announced it will be featured as a presenting company at the H.C. Wainwright Global Life Sciences Conference, a virtual...

AIKI : 0.8905 (-0.54%)
AIkido Pharma Inc. to Present at the H.C. Wainwright Global Life Sciences Conference (Virtual Event)

, /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced it will be featured as a presenting company at the H.C. Wainwright Global Life Sciences Conference, a virtual...

AIKI : 0.8905 (-0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. AIkido Pharma Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 1.0165
2nd Resistance Point 0.9632
1st Resistance Point 0.9269
Last Price 0.8905
1st Support Level 0.8373
2nd Support Level 0.7840
3rd Support Level 0.7477

See More

52-Week High 2.5500
Fibonacci 61.8% 1.7538
Fibonacci 50% 1.5078
Fibonacci 38.2% 1.2618
Last Price 0.8905
52-Week Low 0.4656

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar